Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 45Leukemia, Myeloid, Acute 33Congenital Abnormalities 30Leukemia, Lymphocytic, Chronic, B-Cell 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Breast Neoplasms 23Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Lymphoma, Mantle-Cell 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma 19Multiple Myeloma 18Lymphoma, Non-Hodgkin 18Myelodysplastic Syndromes 17Lymphoma, T-Cell, Cutaneous 15Lymphoma, Large-Cell, Immunoblastic 15Burkitt Lymphoma 15Sezary Syndrome 14Myeloproliferative Disorders 14Mycosis Fungoides 14Blast Crisis 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Hodgkin Disease 13Waldenstrom Macroglobulinemia 10Primary Myelofibrosis 10Neoplasms, Plasma Cell 10Lymphoma, Large-Cell, Anaplastic 10Leukemia, Megakaryoblastic, Acute 10

Interventions

pembrolizumab 161Carboplatin 145Paclitaxel 125Cyclophosphamide 94130-nm albumin-bound paclitaxel 66Capecitabine 64Gemcitabine 54Doxorubicin 50Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 41Cisplatin 38sacituzumab govitecan 34Nivolumab 34olaparib 32Epirubicin 32Specimen Handling 28Docetaxel 28eribulin 27Bevacizumab 26durvalumab 25Drug Therapy 25Biopsy 24camrelizumab 23Magnetic Resonance Spectroscopy 22toripalimab 19Radiotherapy 17spartalizumab 16Everolimus 15veliparib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Flow Cytometry × Clear all
NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡